Fortis Frontier PLC (AIM:FORF)

London flag London · Delayed Price · Currency is GBP · Price in GBX
7.75
0.00 (0.00%)
At close: Mar 6, 2026
-53.03%
Market Cap 4.00M
Revenue (ttm) 3.22M
Net Income (ttm) -1.94M
Shares Out 51.60M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 77,347
Average Volume 35,365
Open 7.75
Previous Close 7.75
Day's Range 7.12 - 7.37
52-Week Range 6.00 - 17.00
Beta 0.20
RSI 37.85
Earnings Date Jun 5, 2026

About Fortis Frontier

Fortis Frontier PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. The company offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, and vitamin D rapid test; and weight management tests that includes weight management DNA and blood tests, glucose management DNA tests, and thyroid pro... [Read more]

Industry Shell Companies
Sector Financials
Founded 2008
Employees 14
Stock Exchange London Stock Exchange AIM
Ticker Symbol FORF
Full Company Profile

Financial Performance

In 2024, Fortis Frontier's revenue was 3.61 million, a decrease of -67.14% compared to the previous year's 10.98 million. Losses were -1.79 million, 1023.3% more than in 2023.

News

There is no news available yet.